Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wilcox

Showing results (411-420 of 454) with videos related to

Pageof 46
Sort By:
British Medical Journal (Clinical Research Ed.)|November 8, 1986
Trial of early nifedipine in acute myocardial infarction: the Trent studyR G Wilcox, J R Hampton, D C Banks, et al.
The American Journal of Cardiology|August 11, 2014
Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study)Robert C Welsh, Frans Van de Werf, Cynthia M Westerhout, et al.
European Heart Journal|November 1, 2001
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarctionJ Llevadot, R P Giugliano, E M Antman, et al.
Circulation|July 13, 2000
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trialC P Cannon, C H McCabe, R G Wilcox, et al.
Metabolism: Clinical and Experimental|November 17, 2009
Dysregulation of sterol regulatory element binding protein-1c in livers of morbidly obese women is associated with altered suppressor of cytokine signaling-3 and signal transducer and activator of transcription-1 signalingMarshall B Elam, Chandrahasa Yellaturu, George E Howell, et al.
Radiology|April 23, 2024
MRI in the Evaluation of Cryptogenic Stroke and Embolic Stroke of Undetermined SourceJiayu Xiao, Roy A Poblete, Alexander Lerner, et al.
The American Journal of Cardiology|December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary ArteriesE M Ohman, P W Armstrong, H D White, et al.
JAMA|March 13, 1996
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigatorsW D Weaver, H D White, R G Wilcox, et al.
European Heart Journal|February 10, 2000
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUITK M Akkerhuis, J W Deckers, E Boersma, et al.
European Heart Journal|April 1, 2005
Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trialBrahmajee K Nallamothu, Eric R Bates, Judith S Hochman, et al.
Pageof 46

Showing results (411-420 of 454) with videos related to

Sort By:
Pageof 46
British Medical Journal (Clinical Research Ed.)|November 8, 1986
Trial of early nifedipine in acute myocardial infarction: the Trent studyR G Wilcox, J R Hampton, D C Banks, et al.
The American Journal of Cardiology|August 11, 2014
Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study)Robert C Welsh, Frans Van de Werf, Cynthia M Westerhout, et al.
European Heart Journal|November 1, 2001
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarctionJ Llevadot, R P Giugliano, E M Antman, et al.
Circulation|July 13, 2000
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trialC P Cannon, C H McCabe, R G Wilcox, et al.
Metabolism: Clinical and Experimental|November 17, 2009
Dysregulation of sterol regulatory element binding protein-1c in livers of morbidly obese women is associated with altered suppressor of cytokine signaling-3 and signal transducer and activator of transcription-1 signalingMarshall B Elam, Chandrahasa Yellaturu, George E Howell, et al.
Radiology|April 23, 2024
MRI in the Evaluation of Cryptogenic Stroke and Embolic Stroke of Undetermined SourceJiayu Xiao, Roy A Poblete, Alexander Lerner, et al.
The American Journal of Cardiology|December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary ArteriesE M Ohman, P W Armstrong, H D White, et al.
JAMA|March 13, 1996
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigatorsW D Weaver, H D White, R G Wilcox, et al.
European Heart Journal|February 10, 2000
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUITK M Akkerhuis, J W Deckers, E Boersma, et al.
European Heart Journal|April 1, 2005
Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trialBrahmajee K Nallamothu, Eric R Bates, Judith S Hochman, et al.
Pageof 46